Title

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel

Publication Date

2022

Content Type

Article

PubMed ID:

36368161

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS